Literature DB >> 22795219

The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.

Chen Li1, Songyi Xu, Avrum I Gotlieb.   

Abstract

Calcific aortic valve disease (CAVD) is the most common form of heart valve disease in Western society and results in the second most common cardiovascular surgery performed. Despite its prevalence, high morbidity, and high mortality, the pathogenesis of CAVD still eludes our understanding. This review article brings together experimental in vivo and in vitro as well as human in vivo research in cell and molecular pathobiology to construct an overarching hypothesis regarding the development and progression of CAVD. We focus on injury, cell dysfunction, and disruptive biologic and physical forces, and how they function in positive feedback loops that result in the eventual calcification of the valve. We propose that injury, inflammation, matrix remodeling, and physical forces are all processes that influence each other and alter the normal physiologic functions of a key player in the pathogenesis of CAVD: the valve interstitial cell. We propose that the different phenotypes of the valve interstitial cell play essential roles in the pathogenesis of CAVD. We describe important physiologic processes which become dysfunctional including proliferation, migration, secretion of growth factors, chemokines and cytokines, and matrix remodeling. We also describe the emergence of chondrogenesis and osteogenesis in the fibrotic valve that lead to the severe clinical conditions of CAVD. CAVD appears to have a complex pathogenesis which fortunately can be studied in vitro and in vivo to identify ways to detect, treat, and prevent CAVD.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795219     DOI: 10.1016/j.carpath.2012.06.005

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  30 in total

1.  S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.

Authors:  Ling Yan; Liby Mathew; Bijoy Chellan; Brandon Gardner; Judy Earley; Tipu S Puri; Marion A Hofmann Bowman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

2.  Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease.

Authors:  Ana M Porras; Jennifer A Westlund; Austin D Evans; Kristyn S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

3.  Notch1 Mutation Leads to Valvular Calcification Through Enhanced Myofibroblast Mechanotransduction.

Authors:  Joseph Chen; Larisa M Ryzhova; M K Sewell-Loftin; Christopher B Brown; Stacey S Huppert; H Scott Baldwin; W David Merryman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-05-28       Impact factor: 8.311

4.  Cadherin-11 as a regulator of valve myofibroblast mechanobiology.

Authors:  Meghan A Bowler; Matthew R Bersi; Larisa M Ryzhova; Rachel J Jerrell; Aron Parekh; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-25       Impact factor: 4.733

5.  The role of valvular endothelial cell paracrine signaling and matrix elasticity on valvular interstitial cell activation.

Authors:  Sarah T Gould; Emily E Matherly; Jennifer N Smith; Donald D Heistad; Kristi S Anseth
Journal:  Biomaterials       Date:  2014-01-24       Impact factor: 12.479

Review 6.  Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics.

Authors:  W David Merryman; Frederick J Schoen
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

7.  Valve interstitial cell tensional homeostasis directs calcification and extracellular matrix remodeling processes via RhoA signaling.

Authors:  Emily J Farrar; Varsha Pramil; Jennifer M Richards; Christopher Z Mosher; Jonathan T Butcher
Journal:  Biomaterials       Date:  2016-07-29       Impact factor: 12.479

8.  Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation.

Authors:  Neil Venardos; Nicole A Nadlonek; Qiong Zhan; Michael J Weyant; Thomas Brett Reece; Xianzhong Meng; David A Fullerton
Journal:  J Surg Res       Date:  2014-03-22       Impact factor: 2.192

9.  Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture.

Authors:  Bin Duan; Ziying Yin; Laura Hockaday Kang; Richard L Magin; Jonathan T Butcher
Journal:  Acta Biomater       Date:  2016-03-03       Impact factor: 8.947

Review 10.  In vitro models of aortic valve calcification: solidifying a system.

Authors:  Meghan A Bowler; W David Merryman
Journal:  Cardiovasc Pathol       Date:  2014-08-15       Impact factor: 2.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.